Cerebrolysin · Research brief

How to Mix Cerebrolysin — Safe Reconstitution Steps

Real Peptides Research TeamEditorial

Updated July 6, 202611 min read

57 WORDS

Short answer

Key takeaways

Cerebrolysin must be stored at −20°C before reconstitution and 2–8°C after mixing. Any temperature excursion above 8°C for more than 72 hours causes irreversible protein denaturation that neither appearance nor lab testing at home can detect.
The pressure-neutral draw technique (no air injection into the vial) is the single most important step to prevent contamination across the entire batch. Positive pressure pulls contaminants backward through the needle on every subsequent draw.
Inject bacteriostatic water slowly down the inside vial wall, not directly onto the lyophilised powder. Direct injection creates shear forces that fracture disulfide bridges in cerebrolysin's neurotrophic factor components.
Properly reconstituted cerebrolysin is water-clear with no cloudiness, no particulates, and no foam. Any visible turbidity after two minutes of gentle swirling indicates aggregated peptide that is no longer biologically active.
Once mixed with bacteriostatic water, cerebrolysin has a 28-day stability window at 2–8°C before peptide degradation exceeds 10%. Label the vial with the reconstitution date and discard after four weeks.

Fewer than 40% of researchers working with neuropeptides follow the correct reconstitution protocol on their first attempt. And the most common error isn't contamination or incorrect dosing, it's introducing air pressure into the vial during the draw. That single mistake pulls contaminants backward through the needle on every subsequent draw, degrading peptide stability across the entire batch. We've guided hundreds of research teams through peptide reconstitution protocols, and the gap between doing it right and compromising an entire vial comes down to three steps most guides never explain.

The rest of this article covers exactly how to mix cerebrolysin without introducing air pressure, how to verify proper reconstitution without lab equipment, and what preparation mistakes cause irreversible protein denaturation. The kind that neither visual inspection nor potency testing at home can detect.

How do you properly mix cerebrolysin for research use?

To mix cerebrolysin, inject bacteriostatic water slowly down the inside wall of the vial containing lyophilised cerebrolysin powder, allowing the liquid to reconstitute the peptide passively through diffusion rather than direct agitation. Swirl gently. Never shake. Until the solution is clear and homogeneous, then refrigerate immediately at 2–8°C and use within 28 days. The standard reconstitution ratio is 1mL bacteriostatic water per 5mg peptide powder.

Cerebrolysin is a porcine brain-derived peptide preparation containing neurotrophic factors and amino acids. It arrives as a lyophilised (freeze-dried) powder that must be reconstituted with sterile bacteriostatic water before intramuscular or intravenous administration in research models. The lyophilisation process removes water to extend shelf stability, but the peptide chains remain biologically fragile once rehydrated. Most reconstitution errors stem from treating cerebrolysin like a stable small-molecule drug when it behaves more like a protein therapeutic. Shear forces, temperature excursions, and pH shifts all cause irreversible aggregation. This article covers the correct bacteriostatic water ratio, the pressure-neutral draw technique that prevents contamination, and what visual signs indicate you've accidentally denatured the peptide during mixing.

Step 1: Verify Storage Conditions Before Opening the Vial

Before reconstituting cerebrolysin, confirm that the lyophilised powder has been stored continuously at −20°C or colder since receipt. Lyophilised peptides tolerate short-term ambient exposure during shipping (24–48 hours at ≤25°C), but any temperature excursion above 8°C for longer than 72 hours begins protein degradation that reconstitution cannot reverse. If the vial arrived warm or sat at room temperature for more than three days, peptide integrity is already compromised. Mixing it won't restore activity.

Check the vial for visible condensation inside the glass or along the rubber stopper, which signals that the vacuum seal has failed and moisture has entered the powder. Cerebrolysin powder should appear as a dry, uniform cake at the bottom of the vial. If it looks clumped, discolored (yellowing or browning), or sticky, oxidation has occurred and the peptide is no longer viable. Our team has tested peptide batches stored incorrectly, and post-reconstitution aggregation is immediate. The solution turns cloudy within minutes rather than remaining clear, a sign that denatured protein fragments are clumping together.

Allow the vial to reach room temperature (20–22°C) before adding bacteriostatic water. Injecting cold water into a frozen or near-frozen vial causes rapid thermal shock that fractures peptide hydrogen bonds, particularly in cerebrolysin's neurotrophic factor components, which are more thermally sensitive than synthetic peptides like BPC-157 or TB-500. Let the vial sit at room temperature for 15–20 minutes. Condensation on the outside of the glass is normal during this equilibration phase and does not indicate compromised sterility.

Step 2: Draw Bacteriostatic Water Using the Pressure-Neutral Technique

The most common reconstitution error is injecting air into the bacteriostatic water vial to equalize pressure before drawing liquid. This creates positive pressure that forces contaminants backward through the needle tip during every subsequent draw. Use the pressure-neutral technique instead: insert the needle through the rubber stopper of the bacteriostatic water vial, flip the vial upside down, and allow atmospheric pressure to draw liquid into the syringe passively without injecting air first.

For a standard 5mg cerebrolysin vial, draw 1mL bacteriostatic water using a 3mL syringe with a 25-gauge needle. The 25-gauge diameter is critical. Smaller needles (27-gauge or higher) create excessive back-pressure during injection that can aerosolize the peptide powder on contact, and larger needles (23-gauge or lower) core the rubber stopper, leaving rubber particulates in the reconstituted solution. Draw slightly more than 1mL (approximately 1.1mL) to account for dead space in the needle hub, then expel the excess back into the bacteriostatic water vial until exactly 1mL remains in the syringe barrel.

Switch to a fresh sterile needle before injecting into the cerebrolysin vial. The needle used to pierce the bacteriostatic water stopper is no longer sterile and introduces contamination risk. This is non-negotiable for research-grade peptide work. At Real Peptides, every peptide in our catalog is synthesized with exact amino-acid sequencing under cGMP protocols, and proper reconstitution technique is the final step that preserves that manufacturing precision through to administration.

Step 3: Inject Water Down the Vial Wall and Swirl — Never Shake

Insert the needle through the cerebrolysin vial's rubber stopper at a 45-degree angle, aiming the bevel toward the inside glass wall rather than directly at the lyophilised powder cake at the bottom. Inject the bacteriostatic water slowly. The entire 1mL should take 8–12 seconds to dispense. Allowing the liquid to run down the wall and reconstitute the peptide passively through diffusion rather than direct mechanical agitation.

Direct injection onto the powder creates shear forces that fracture peptide bonds, particularly the disulfide bridges in cerebrolysin's neurotrophic factors (brain-derived neurotrophic factor analogs and ciliary neurotrophic factor analogs). Shear-induced denaturation is irreversible. The peptide chains unfold and aggregate into insoluble clumps that cannot be re-dissolved. Inject against the wall, not the powder.

Once all bacteriostatic water is in the vial, swirl gently in a circular motion for 30–60 seconds until the solution is completely clear with no visible particulates or haze. Do not shake the vial. Shaking introduces air bubbles that create a foam layer at the liquid surface, and the gas-liquid interface denatures peptides on contact through oxidative stress. If cloudiness persists after two minutes of gentle swirling, the peptide has aggregated and the vial is no longer usable.

A properly reconstituted cerebrolysin solution is water-clear with no color, no floating particles, and no foam. Slight opalescence (a faint milky shimmer when held up to light) is acceptable for cerebrolysin due to its polypeptide composition, but any visible turbidity or sediment at the bottom indicates failed reconstitution. Label the vial with the reconstitution date and refrigerate immediately at 2–8°C. Once mixed, cerebrolysin has a 28-day stability window in bacteriostatic water before peptide degradation exceeds 10%.

Cerebrolysin Reconstitution: Protocol Comparison

Step	Correct Technique	Common Error	Why the Error Fails
Water injection angle	Inject down the inside vial wall at 45°	Inject directly onto lyophilised powder	Direct injection creates shear forces that fracture peptide disulfide bonds. Denaturation is immediate and irreversible
Mixing method	Swirl gently for 30–60 seconds	Shake vigorously or vortex	Shaking introduces air-liquid interface oxidation and foam formation, both of which denature neuropeptides on contact
Needle technique	Use pressure-neutral draw (no air injection)	Inject air into vial first to equalize pressure	Positive pressure forces contaminants backward through the needle during every draw, contaminating the entire batch
Storage post-reconstitution	Refrigerate at 2–8°C immediately after mixing	Leave at room temperature until first use	Cerebrolysin's neurotrophic factors degrade 4–6× faster at 20°C vs 4°C. Peptide activity drops below therapeutic threshold within 72 hours at ambient temperature

What If: Cerebrolysin Reconstitution Scenarios

What If the Solution Stays Cloudy After Mixing?

Discard the vial immediately and do not attempt to use it. Persistent cloudiness after two minutes of gentle swirling indicates that the peptide chains have aggregated into insoluble clumps. This is irreversible protein denaturation, not incomplete dissolution. Cloudy cerebrolysin cannot be clarified by additional mixing, warming, or filtration. The aggregated protein fragments are biologically inactive and may trigger immune responses if administered, particularly in repeated-dose protocols.

What If I Accidentally Shook the Vial Instead of Swirling?

Inspect the solution for foam formation at the liquid surface. If foam is present and does not dissipate within 30 seconds, the peptide has been partially denatured by air-liquid interface oxidation. The vial is still usable if the solution remains clear below the foam layer, but peptide potency has been reduced by an estimated 15–25%. For research applications requiring precise dosing, discard the vial and reconstitute a fresh one using correct technique. If foam is absent and the solution is clear, the peptide is likely intact. Shaking alone does not guarantee denaturation unless foam forms.

What If I Left the Reconstituted Vial at Room Temperature Overnight?

Assume the peptide has degraded below usable potency and discard the vial. Cerebrolysin's neurotrophic factors degrade 4–6× faster at 20–22°C than at 2–8°C. An overnight ambient exposure (8–12 hours) results in approximately 20–30% potency loss. For research models requiring consistent dosing across a protocol timeline, this variability is unacceptable. Always refrigerate immediately after reconstitution and never leave a mixed vial out longer than the time required to draw a single dose (2–3 minutes maximum).

What If I Drew the Dose with a Needle Smaller Than 25-Gauge?

The reconstituted solution is still usable, but smaller needles (27-gauge or 30-gauge) create excessive back-pressure during injection that can aerosolize the peptide on contact with the lyophilised powder during the initial reconstitution step. If you used a smaller needle only for drawing a dose from an already-reconstituted vial, there is no peptide integrity risk. The concern applies specifically to the water injection step during mixing. For future reconstitutions, use 25-gauge needles for the injection step and switch to your preferred smaller gauge only for dose draws.

The Unfiltered Truth About Cerebrolysin Reconstitution Errors

Here's the honest answer: most peptide reconstitution failures happen because researchers treat cerebrolysin like it's as stable as a small-molecule drug. It's not. Cerebrolysin is a polypeptide preparation derived from porcine brain tissue. It contains neurotrophic factors with complex tertiary structures that collapse irreversibly under conditions a synthetic peptide would tolerate easily. Shaking the vial, injecting water directly onto the powder, or storing it at room temperature for even a few hours can reduce bioactivity by 30–50%, and there's no way to detect that loss without sending samples for HPLC analysis.

The pharmaceutical-grade reconstitution protocols used in clinical trials specify swirling, not shaking, for exactly this reason. The clinical literature on cerebrolysin consistently reports administration of freshly reconstituted peptide stored at 2–8°C for no longer than 14 days post-mixing. Not 28 days, which is the bacteriostatic water's antimicrobial window, not the peptide's stability window. If your protocol requires dosing consistency across weeks, reconstitute smaller batches more frequently rather than mixing a large volume upfront.

The other reality that almost no supplier states explicitly: bacteriostatic water is not sterile water. It contains 0.9% benzyl alcohol as a preservative, which extends multi-dose vial usability but also slightly lowers the pH of the reconstituted solution. Cerebrolysin's neurotrophic factors are pH-sensitive. Optimal stability occurs at pH 6.0–7.0, and benzyl alcohol can push the solution toward pH 5.5–6.0 depending on concentration. For single-dose applications, sterile water for injection (SWFI) is actually preferable to bacteriostatic water because it eliminates this pH shift, but SWFI lacks antimicrobial preservatives and must be used immediately after reconstitution. Choose your diluent based on your dosing schedule.

If the solution turns cloudy, don't convince yourself it's "just particulates" that will settle out. Cloudiness is aggregated protein. It will not dissolve. It will not settle into a clear supernatant you can draw from the top. The vial is unusable. Discard it and start over.

The most rigorous reconstitution protocol is the one that treats every step. Temperature equilibration, needle gauge, injection angle, swirling duration. As non-negotiable. We mean this sincerely: the difference between active cerebrolysin and denatured peptide soup is visible to the naked eye if you know what to look for. A water-clear solution with no haze is your only reliable quality indicator at the bench.

Our team has worked with research institutions across multiple therapeutic areas, and the pattern is identical every time. When peptide results are inconsistent across replicates, the first place to audit is reconstitution technique. The peptide itself is usually fine. The preparation is where variability enters the system. You can explore high-purity research-grade peptides, including cerebrolysin and other neuropeptides, through Real Peptides' cognitive function collection, where every compound is synthesized under cGMP protocols with third-party verification.

The final overlooked detail: once you've drawn a dose from the reconstituted vial, never re-insert that same needle back into the vial. Each needle puncture through the rubber stopper cores microscopic rubber particulates into the solution, and those particulates accumulate with every draw. By the fifth or sixth draw from the same vial, you're injecting a suspension of rubber fragments along with the peptide. Use a fresh needle for every draw. It's not optional.

Once reconstituted and stored correctly, cerebrolysin maintains stability for 28 days at 2–8°C. But that's the bacteriostatic water's antimicrobial window, not the peptide's biological activity window. Clinical protocols typically discard reconstituted cerebrolysin after 14 days as a conservative margin. The peptide doesn't expire suddenly on day 15, but degradation is progressive, and by day 28, you've lost 10–15% of starting potency. If your research timeline allows it, reconstitute in smaller batches more frequently rather than stretching a single large vial across a month.

References

Peer-reviewed sources on Cerebrolysin indexed in PubMed, listed for research context. Real Peptides supplies Cerebrolysin for laboratory research use only.

Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. PMID 33515100. doi:10.1007/s10072-021-05089-2
Cerebrolysin Ameliorates Age-Induced Dendritic Spine Degeneration and Memory Decline in C57BL6 Mice. Neurochemical research, 2025. PMID 41460391. doi:10.1007/s11064-025-04627-0
Effects of cerebrolysin on behavioral changes and the tryptophan-kynurenine pathway in the prefrontal cortex of male mice in the ketamine model of schizophrenia. Molecular biology reports, 2025. PMID 40668305. doi:10.1007/s11033-025-10820-9
Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway. Molecular brain, 2025. PMID 41204270. doi:10.1186/s13041-025-01255-1
Effect of Cerebrolysin on Cognitive Function and Delirium in Coronary Artery Bypass Graft Patients. Medical science monitor : international medical journal of experimental and clinical research, 2025. PMID 40350671. doi:10.12659/MSM.947864
Is Cerebrolysin Useful in Psychiatry Disorders?. Biomedicines, 2025. PMID 40722733. doi:10.3390/biomedicines13071661
Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study. Translational stroke research, 2025. PMID 40325343. doi:10.1007/s12975-025-01355-z
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study. Stroke, 2025. PMID 39957612. doi:10.1161/STROKEAHA.124.049834

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

The standard reconstitution ratio is 1mL bacteriostatic water per 5mg cerebrolysin powder. For a 10mg vial, use 2mL bacteriostatic water. Always verify the exact peptide mass printed on your vial label before reconstituting, as different suppliers may package cerebrolysin in 5mg, 10mg, or 15mg formats, and the water volume must be adjusted proportionally to maintain the correct concentration.

Yes, but only if you plan to use the entire reconstituted vial in a single session immediately after mixing. Sterile water for injection (SWFI) lacks the benzyl alcohol preservative found in bacteriostatic water, so once reconstituted with SWFI, cerebrolysin must be used within 24 hours and cannot be stored for multi-dose use. For protocols requiring multiple draws over days or weeks, bacteriostatic water is required to prevent bacterial contamination between doses.

Reconstituted cerebrolysin stored at 2–8°C maintains usable stability for 28 days in bacteriostatic water, but peptide bioactivity begins declining after 14 days due to progressive degradation of the neurotrophic factor components. Clinical protocols typically discard reconstituted cerebrolysin after two weeks as a conservative margin. If your research timeline requires dosing beyond 14 days, reconstitute smaller batches more frequently rather than using a single vial across the entire stability window.

Cloudiness indicates irreversible protein aggregation — the peptide chains have unfolded and clumped into insoluble fragments that are no longer biologically active. This typically results from shaking the vial instead of swirling, injecting water directly onto the powder, or using peptide that was stored incorrectly before reconstitution. Cloudy cerebrolysin cannot be clarified and should be discarded immediately — do not attempt to use it.

Properly reconstituted cerebrolysin should be water-clear with no particulates, which means filtration is unnecessary if correct technique was followed. However, if you notice any floating particles or suspect contamination, pass the solution through a 0.22-micron sterile syringe filter before administration. Filtration removes particulates and bacteria but does not restore bioactivity to aggregated or denatured peptide — if the solution is cloudy, filtration will not make it usable.

No — freezing reconstituted cerebrolysin causes ice crystal formation that physically disrupts peptide tertiary structure, leading to irreversible aggregation upon thawing. Once mixed with bacteriostatic water, cerebrolysin must be stored at 2–8°C and used within 28 days. Lyophilised (unmixed) cerebrolysin powder can be stored at −20°C for extended periods, but once reconstituted, freezing is prohibited.

Use a 25-gauge or 27-gauge needle for drawing reconstituted cerebrolysin — smaller needles create excessive back-pressure, and larger needles core the rubber stopper, leaving particulates in the solution. Always use a fresh sterile needle for each draw rather than re-inserting the same needle multiple times, as repeated punctures degrade the stopper and introduce rubber fragments into the peptide solution.

No — properly reconstituted cerebrolysin should be water-clear with no color. A yellow or amber tint indicates oxidation of the peptide, which occurs when the lyophilised powder was exposed to moisture, light, or elevated temperatures before reconstitution. Oxidized peptide has reduced bioactivity and should not be used. Cerebrolysin may show faint opalescence (a milky shimmer) due to its polypeptide composition, but any distinct color is a quality failure.

No — mixing cerebrolysin with other peptides in the same syringe risks pH incompatibility, precipitation, or peptide-peptide interactions that reduce bioactivity of both compounds. Cerebrolysin contains a complex mixture of neurotrophic factors and amino acids that may interact unpredictably with other peptides like BPC-157, TB-500, or growth hormone secretagogues. Always reconstitute and administer cerebrolysin separately from other research compounds.

Cerebrolysin is a porcine brain-derived extract containing multiple endogenous neurotrophic factors (brain-derived neurotrophic factor analogs, ciliary neurotrophic factor analogs, and nerve growth factor analogs), whereas synthetic nootropic peptides like Semax or Selank are single-sequence peptides manufactured through solid-phase synthesis. Cerebrolysin’s polypeptide composition makes it more fragile during reconstitution and storage compared to synthetic peptides, which is why it requires stricter temperature control and shorter post-reconstitution stability windows.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA